Results 221 to 230 of about 37,687 (273)
Immunomodulatory metabolites in rheumatic diseases. [PDF]
EULAR Rheumatol OpenYamamoto K.
europepmc +1 more source
Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition [PDF]
Frontiers in Molecular Biosciences, 2019 The kynurenine pathway is the major route for tryptophan metabolism in mammals. Several of the metabolites in the kynurenine pathway, however, are potentially toxic, particularly 3-hydroxykynurenine, 3-hydroxyanthranilic acid, and quinolinic acid. Quinolinic acid (QUIN) is an excitotoxic agonist at the NMDA receptor, and has been shown to be elevated ...
Robert Phillips, J Phillip Bowen
exaly +6 more sources
Biochimica Et Biophysica Acta - General Subjects, 2005 The gene coding for arylformamidase (Afmid, also known as kynurenine formamidase) was inactivated in mice through the removal of a shared bidirectional promoter region regulating expression of the Afmid and thymidine kinase (Tk) genes. Afmid/Tk-deficient
John Casida +2 more
exaly +10 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Advances in kynurenine analysis
Clinica Chimica Acta, 2023Kynurenine, the first product of tryptophan degradation via the kynurenine pathway, has become one of the most frequently mentioned biomarkers in recent years. Its levels in the body indicate the state of the human physiology. Human serum and plasma are the main matrixes used to evaluate kynurenine levels and liquid chromatography is the dominant ...
FrantiĊĦek Svec
exaly +3 more sources
Kynurenine metabolism in health and disease
Amino Acids, 2010 Kynurenine is a small molecule derived from tryptophan when this amino acid is metabolised via the kynurenine pathway. The biological activity of kynurenine and its metabolites (kynurenines) is well recognised.
Williams, Richard +7 more
exaly +2 more sources